Trusted partner in preventative medical technology. Empowering physicians with tools for early detection, personalized care, and progress monitoring.
TITN-Brand-Bible.md) and the Claude Code memory (titn_branding.md). Version 1.5 · Logo system Pulse v2 + Clinic OS report-assist note (DRAFT, pending FDA review) · Last updated 2026-06-05.
Everything you need to know to talk about TITN correctly, in 30 seconds.
The foundational tone for everything TITN does. When in doubt about voice, positioning, or whether a claim is honest, return to this quote.
Before medicine rushes to sell miracles, it must first measure truth. True wellness is proven in baselines, not promises. A health center that cannot demonstrate efficacy through rigorous testing is not practicing care but marketing.
This is the through-line for every TITN deliverable: web copy, sales pitches, slides, client emails, training materials, marketing video, social posts. The whole TITN model (baseline diagnostics, therapeutic intervention, interval retesting, BMTG clinical interpretation) exists because of this principle.
No therapeutic recommendation without an objective baseline.
Retesting at intervals shows whether the intervention actually moved the needle, in numbers.
If a claim can't be demonstrated through biomarker data or trend graphs, it doesn't go in the copy.
Transparency isn't a feature for TITN; it's the foundation.
The transparency principle applies to TITN's own claims first. Every number, statistic, and timeline in TITN copy traces to one of these sources:
If a claim doesn't trace to one of those sources, it doesn't go in TITN copy. When you see a specific number in this bible, it has a source. When you see directional language ("typically," "in our experience," "varies by payer"), it means we're being honest that the specific number depends on context.
TITN gives traditional medical practices a confident way into functional and preventive medicine. Diagnostic tests are FDA-cleared and reimbursed by Medicare, Medicaid, and most insurance, so revenue starts day one. Every test sits inside a baseline, treat, retest methodology that proves what's actually working in numbers, not patient impressions. And every device comes with white-glove support: clinical training, billing setup, technical implementation, ongoing help, continuing education. You don't have to become a functional medicine expert or a billing expert. We carry that weight.
TITN's canonical proof bar: the small tone-keyword strip placed under the wordmark on every TITN deliverable, docs, decks, one-pagers, web headers, email, copy. One bar, identical everywhere.
Three sizes for three contexts. All FDA references reflect the current three-module clearance for the ANS+ TM Flow System (K173696 vascular, K152216 sudomotor, K200141 HRV).
Dollar ranges below ($300 to $400 per autonomic test, $600 to $800 per brain assessment, $350 to $500 cash-pay) reflect typical reimbursement from TITN's aggregated EOB billing data across partner practices. Actual amounts vary by payer, plan, region, and patient eligibility. FDA K-numbers are verifiable in the FDA 510(k) database. CPT codes are verifiable through CMS. See Section 02 (How we back our claims) for the full source list.
"Transition It Now helps traditional medical practices add functional and preventive medicine as a real revenue line, not a cash-pay experiment. The diagnostic tests are FDA-cleared and insurance-reimbursed: TM-Flow at $300 to $400 per autonomic test, WAVi at $600 to $800 per brain assessment. We do baseline, treat, and retest, so you can show patients and carriers exactly what changed in numbers. Every report comes back on our HIPAA-compliant portal with template visuals. For med-legal TBI cases, BMTG adds a board-certified neurologist signature on a Brainwave Report."
Transition It Now (TITN) partners with traditional medical practices entering functional and preventive medicine. The FDA-cleared diagnostic platforms are reimbursed by Medicare, Medicaid, and most insurance: TM-Flow System (three-module clearance K173696, K152216, K200141) for autonomic and vascular testing at $300 to $400 per reimbursed assessment, and WAVi Scan EEG System (K213900) for brain function at $600 to $800 per evaluation. Plus medical-grade photobiomodulation for treatment, two-track BMTG interpretation (MCI Reports for clinical via TITN's HIPAA portal, BWRs signed by Dr. Asad for med-legal TBI cases). Every device comes with white-glove support: clinical training, billing setup, technical implementation, ongoing tech support, and continuing education. The methodology is baseline, treat, retest, so practices document what's actually working through objective biomarkers, not patient impressions.
"Transition It Now helps traditional medical practices add functional and preventive medicine without taking financial risk. The diagnostic tests are FDA-cleared and reimbursed by Medicare, Medicaid, and most insurance, so revenue starts day one.
Three core platforms: TM-Flow for autonomic and vascular testing at $300 to $400 per reimbursed test, cleared as a three-module FDA platform. WAVi Scan for objective brain function assessment at $600 to $800 per evaluation. And medical-grade photobiomodulation from Hue Light for treatment. Every WAVi and ANS+ report comes back through our HIPAA-compliant portal with TITN template visuals, interpreted by a BMTG team neurologist or your own. For med-legal TBI cases, BMTG adds a Dr. Asad neurologist signature on a Brainwave Report.
What makes TITN different is the retest methodology. We establish a baseline, implement the therapeutic intervention, then retest at intervals using the same protocol. So instead of asking a patient if they feel better, you're showing them, and their insurance carrier, exactly what changed in numbers. Reimbursable revenue for the practice. Objective evidence for the patient."
"Transition It Now specializes in helping traditional medical practices take their first confident steps into functional and preventive medicine.
Our Company Evolution: We began as a company helping medical practices transition to digital systems and operations. Ten years ago, we made a strategic pivot, focusing exclusively on the medical space and specifically on helping traditional doctors expand into functional and preventive medicine. We recognized that the barrier wasn't knowledge or interest, it was financial risk and uncertainty about what actually works.
Our solution? Hybrid FDA-cleared diagnostic technologies that are fully insurance-reimbursed, creating practice ROI while simultaneously providing objective proof of therapeutic efficacy through retesting and health trend documentation.
Our Core Diagnostic Technologies: The ANS+ TM Flow System is FDA cleared as a three-module platform (K173696 for vascular, K152216 for sudomotor, K200141 for HRV) and represents our primary entry point for traditional practices. This comprehensive platform is covered by Medicare, Medicaid, and most insurance carriers, generating $300-$400 per test on average through insurance reimbursement. For uninsured patients, cash-pay pricing ranges from $350-$500.
The system provides three distinct billable tests: CPT code 95921 for cardiovascular autonomic function testing, 95923 for sudomotor evaluation detecting small fiber neuropathy, and 93922 for ankle-brachial index assessing peripheral vascular disease.
The WAVi Scan EEG System, FDA cleared under K213900, provides objective brain function assessment for cognitive health evaluation, concussion management, ADHD assessment, anxiety and depression profiling, traumatic brain injury documentation, and age-related cognitive decline monitoring. Practices charge $600-$800 per comprehensive assessment with recommended biannual retesting.
Expert Clinical Interpretation, Two Tracks: Through Brainwave Medtech Group, our sister company, we provide the interpretation layer in two distinct deliverables. The MCI Report is the clinical track: ANS+ autonomic data and WAVi brain assessments delivered through TITN's HIPAA-compliant portal with our template visuals and wording, interpreted by a BMTG team neurologist or by the practice's own neurologist using our templates. The Brainwave Report (BWR) is the med-legal track: WAVi-only, signed by Dr. Syed Asad (board-certified neurologist), court-admissible, used by attorneys handling traumatic brain injury, dysautonomia, and personal-injury cases.
Medical-Grade Therapeutic Systems: We partner exclusively with Hue Light USA for photobiomodulation therapy. Their Whole-Body PBM Chamber features 38,880 medical-grade LED diodes delivering multiple therapeutic wavelengths: 530nm green light for migraine management, 660nm red light for tissue repair, 850nm near-infrared for deep pain management, and 940nm infrared for the deepest systemic effects. The critical specification is medical-grade irradiance, 70-90 milliwatts per square centimeter, ensuring therapeutic dosing in 10-15 minute sessions rather than 45 minutes with consumer devices.
Our Distinctive Methodology (Proving What Actually Works: First, we establish comprehensive diagnostic baselines using ANS+ autonomic testing and WAVi brain assessment. Second, patients undergo specific therapeutic interventions with documented treatment parameters. Third, at defined intervals) typically 4-6 weeks for acute conditions, 12 weeks for chronic, we retest using identical diagnostic protocols. Fourth, we create comprehensive health trend graphs tracking biomarkers over multiple timepoints.
For traditional doctors, it provides objective proof of which interventions actually work. For patients, it transforms 'I feel a little better' into a side-by-side report showing exactly what changed in their own nervous system, cognitive function, or vascular markers from baseline to retest. The specific numbers come from each patient's own data, never pre-promised by TITN. For insurance, it provides medical necessity documentation. For medical-legal cases, it offers court-admissible documentation. For practice differentiation, it positions doctors as leaders in evidence-based, objective medicine.
Our Mission: We exist to help traditional medical practices confidently expand into functional and preventive medicine by providing FDA-cleared diagnostic technologies that are insurance-reimbursed, creating immediate practice ROI, while simultaneously proving through systematic retesting which treatments actually improve patient health through objective biomarkers."
Doctors are smart, but most have not been deeply trained in the science behind what TITN provides. Medical school and most residencies don't go deep on functional medicine, autonomic neurology, biomarker interpretation, photobiomodulation, or quantitative EEG. The autonomic nervous system in particular is overwhelming on first encounter, even neurologists rarely have deep clinical ANS-testing exposure (most see ANS only through dysautonomia consults, not as a testable, monitorable system).
Our rule across every touchpoint, training, product docs, sales, technical support, marketing, patient materials we provide:
When this is done well, the doctor moves from "this looks complex and risky" to "I get it, I can use this, my patients will benefit." That's the win for both sides, they grow their practice, patients improve, TITN gets a long-term partner.
Use these as the first 1 to 2 sentences when reaching out cold or opening a conversation. Each one names the audience's real-world pain in plain English before TITN is even mentioned. Earn the next sentence first.
"How do you currently prove to your patients (and to yourself) that the protocols you're using are actually working? Most clinics rely on patient self-report, which makes everyone uncomfortable. We provide the FDA-cleared, insurance-reimbursed diagnostic tests that let you show real biomarker change over time, not feelings."
"When was the last time you sent a patient for an EEG or ERP and got back an objective report you didn't have to interpret yourself? Our WAVi platform is FDA-cleared for clinical use. Every report comes back on our HIPAA-compliant portal with TITN template visuals, interpreted by a BMTG team neurologist or by your own neurologist using our templates. For med-legal TBI cases, BMTG adds a Dr. Asad neurologist signature on a Brainwave Report. Plus, it's reimbursable."
"Are your TBI and dysautonomia cases relying on subjective patient testimony, or do you have FDA-cleared objective biomarker evidence in the record? We can deliver a Brainwave Report, signed by a board-certified neurologist, that documents the actual brain and autonomic findings. Court-admissible. Available cash-pay or lien-based depending on the case structure."
"If you could add a 10-minute diagnostic test to your existing workflow that's insurance-reimbursed at $300 to $400 per patient, catches early autonomic and vascular changes most labs miss, and doesn't require you to learn a new specialty, would that be worth a 20-minute conversation? Because that's the conversation."
Organized by the Diagnose · Treat · Decode · Grow framework. Cross-reference the FDA Master Tables before any regulated marketing.
The Diagnose / Treat / Decode / Grow framework is internal taxonomy only and must stay off the customer site. The locked customer-facing website navigation, left to right, is:
Diagnostics · Advanced Therapies · Research · Practice Growth · Support · BMTG · Contact
95999 (one unit, NOT unbundled into component codes), because no specific CPT describes a P300 cognitive ERP panel. 99483 (cognitive assessment + care-plan visit) is a SEPARATE ordering-physician service, billed only when its full elements are independently met and documented; it is not part of the scan and not billed by the testing facility. 92650 / 92652 / 92653 / 92585 are all auditory evoked-potential codes, NOT WAVi's cognitive P300 ERP, do not use them. Component codes 95816 / 95957 / 95930 only where independently performed, documented, and payer-recognized. Citation correction: the prior basis, CMS article A56440, was RETIRED effective 11/13/2025 (and was already retired when this correction was first locked 2026-06-06). Verified live 2026-07-13: NO active MAC article, Noridian (California) included, governs this panel, so the 95999 choice rests on general CPT unlisted-code principle, confirmed by the practice's certified coder and its MAC. See the WAVi Coding Reconciliation Note (2026-07-13).Devices alone don't transform a practice. The reason most clinics that buy diagnostic equipment never use it is because the vendor disappears after the sale. TITN doesn't. Every card below answers what you, the practice, actually get. Not what we provide. What you'll have working in your clinic within a few weeks of saying yes.
You and your staff get the training to run the test, interpret the basic patterns, and explain results to patients without a neurology textbook on the desk. Onboarding pace adapts to your practice size and existing expertise.
We coach your billing team through the first cycle so the codes flow correctly. Coverage and actual reimbursement vary by payer, plan, and region.
Device arrives, gets set up, gets validated, and your first test happens with us on the line if you want. You'll have a named TITN technical contact, not a routing queue.
You don't pay full equipment cost out of pocket on day one to find out if patients show up. The first cycles of reimbursement carry the device.
The reason most practices under-promote a new service is because writing the copy is friction. We remove the friction so your front desk is already talking about it.
When something goes sideways during a clinic day, you're calling TITN technical staff who know the device and know your practice. Not an offshore queue.
You don't stagnate after the initial training. TITN runs and sponsors clinical education so partner practices keep advancing.
BMTG delivers two distinct reports so the right neurologist signs the right deliverable. You stay in your specialty either way.
Lead with the support, not the spec sheet. "You're not buying a device. You're buying a fully supported revenue line, with two BMTG report tracks built in." That posture, combined with the founder's transparency principle, is what closes integrative MDs who've been burned by aggressive medical-device sales tactics before.
Brand-level placeholder only. Do not move into client-facing copy until cleared.
TITN Clinic OS is the private-AI layer that assists report interpretation inside the BMTG report pipeline. It reads the finished device report only (never the raw signal, waveform, or image), drafts a plain-language interpretation, and cites every finding to the report's own values and the manufacturer's reference ranges. A board-certified neurologist or the ordering clinician then reviews, edits, and signs every report. The principle is augment, never replace: the AI proposes, a licensed human signs. This keeps the deliverable consistent with the founder's transparency principle (Section 02) and the FDA posture in Section 13.
A flat baseline that runs straight into one tall R-spike dead-center, an S dip, a return to baseline, and a forward arrow. It reads instantly as a pulse and carries the brand idea: measure the body, move the patient forward. The spike is always centered. (The early pre-spike Q hook was removed, see Decisions in Section 08b.)
The visual treatment is the "lightsaber neon" family. On dark, three stacked layers (tight atmospheric halo, mid-glow, sharp bright core) read as a real lit tube. On light, the same DNA inverted: a lighter-blue atmospheric halo (#5AA6F8) surrounds a sharply defined deep-blue body (#1A7BE5). Line ends use a flat butt cap for a sharp, clean termination (no rounded nub); joins stay round so the spike tip and arrow read smooth. The halo is kept tight, crisp lightsaber, not haze (tightened 2026-05-29). Mono cuts run ~1.65x the neon core weight so they carry the same visual mass the glow gives the color versions.
Status: Pulse system (v2), locked 2026-05-29. Current header lockup: Beat on the Approach (titn-beat-d), ratified 2026-08-20, solid-ink law 2026-08-21 (next block). The prior arrow-spike system (v1) is retired to TITN Logos/Archive/; active filenames are preserved so existing references keep working. The brainwave is not in the static mark, it lives in motion (see "Motion: the living signal" below).
This is the lockup on the website header, footer, and favicon, and the default for any new horizontal placement. The pulse line enters from the left, fires the full badge heartbeat in the open run before the wordmark, stops 20 units short of the type, and the right run exits through the arrow. Nothing crosses the letterforms: no clip, no mask, no blur. The icon is the left part alone, which is exactly the badge pulse, so the badge, the favicon, and the lockup are one mark.


Logos/Bold/SVG/titn-beat-d-header-light.svg and -dark.svg (1552 x 208 viewBox)Logos/Bold/SVG/titn-beat-icon-light.svg and -dark.svg (512 x 512 viewBox)Logos/Bold/PNG/: header at 3104 px wide, icon at 1024 px, with and without backgroundWebsite/Landing-Flashy-v1/assets/titn-header-beat-d.svg and titn-icon-beat.svg; the website chrome inlines them.











The bare neon logo does not survive being minimized, the glow swallows the thin core into a fuzzy blob. The minimized mark is a rounded-square badge with a bold, mostly-solid pulse and only a whisper of glow, so when it shrinks the glow goes sub-pixel and the solid mark stays crisp down to 16px. The pulse is a slightly widened diagonal zigzag so it reads as a heartbeat, not a plus, when tiny. Dark is the default; light (frosted white square, solid TITN Blue pulse) is for light-theme tabs and white UI chrome; blue is the vibrant alternate. Favicons render from the dark badge into Bold/favicon/favicon-{16..512}.png and from the light badge into Bold/favicon/favicon-light-{16..512}.png. The light badge exists because the blue-on-light neon cut washes out below ~48px (added 2026-07-05); light contexts get the badge, never the bare mark.
The brand's motion concept, for any GIF, video, web hero, loading state, app splash, or social motion. The static logo is TITN at rest, a clean solid heartbeat. The moment it moves, the brainwave appears:
The clean mark is the brand at rest; in motion you see the living brain-and-body signal underneath. "The line is alive." Pair the rolling ripple with the centered pulse on every animated TITN asset so the motion is unmistakably TITN.
When the wordmark or condensed mark appears with both forms, the "IT" letters get the TITN Light Blue accent (#5AA6F8 on dark, #1A7BE5 on light) while the other letters stay in TITN Black (or white on dark). This reveals the structural meaning of the acronym, Transition IT Now.
The engineering and reasoning behind Section 08, drawn from the Logo System v2 (Pulse) handoff. Use this when you need to reproduce, extend, or defend the mark, rather than just place it. Every lockup, treatment, badge, and favicon comes out of one generator, so edits stay consistent.
Three stacked strokes make a tight, defined glow (a lit tube, not haze). Line ends use a flat butt cap for a sharp termination; joins stay round so the spike tip and arrow read smooth.
#f6f8fc#5AA6F8 at 0.5#1A7BE5#FFFFFF or #060604)Canonical heartbeat path (icon, viewBox 720 x 300). The baseline runs straight into the spike: no pre-spike Q dip.
The angles are fixed constants, exactly like a locked 90° or 45° would be. Never redraw either pulse by eye; copy the canonical path verbatim or regenerate via the generator. Every length is also given relative (as a ratio or a percent of canvas), so when the mark scales up or down every proportion holds automatically. X and Y always scale together (uniform scale only, never stretch), which is what keeps every angle identical at any size.
Wide pulse (icon / glyph / mark / wordmark / horizontal; run x rise at s=1):
| Segment | Run x Rise | Length | Angle (locked) | Relative to R upstroke |
|---|---|---|---|---|
| Baseline (both sides) | flat | varies by lockup | 0.00° always | n/a |
| R upstroke | 15 x 106 | 107.06 | 81.95° | 1.000 |
| R downstroke (to S trough) | 13 x 194 | 194.44 | 86.17° | 1.816 |
| S recovery | 13 x 88 | 88.96 | 81.60° | 0.831 |
| Arrow barbs | 24 x 14 half-height | 27.78 each | 30.26° off baseline | n/a |
R:S amplitude ratio = 106:88 = 1.205:1 (peak above baseline : trough below), the family signature. R apex sits at the exact horizontal center of the signal; on the icon viewBox (720 x 300) the peak is 35.3% of height above baseline, the trough 29.3% below.
Badge pulse (app icon / favicon, viewBox 512 x 512; path locked verbatim: M96,268 L208,268 L244,136 L286,376 L320,268 L416,268):
| Segment | Run x Rise | Length | Angle (locked) | % of canvas (512) |
|---|---|---|---|---|
| Baseline left | 112 x 0 | 112 | 0.00° | 21.9% |
| R upstroke | 36 x 132 | 136.82 | 74.74° | 26.7% |
| R downstroke | 42 x 240 | 243.65 | 80.07° | 47.6% |
| S recovery | 34 x 108 | 113.23 | 72.53° | 22.1% |
| Baseline right | 96 x 0 | 96 | 0.00° | 18.8% |
R:S = 132:108 = 1.222:1 (peak 25.8% of canvas above baseline, trough 21.1% below), same ~1.2 family signature. Badge angles are deliberately ~7° shallower than the wide pulse so the zigzag reads as a heartbeat, not a plus, at 16px: do not "fix" them to match. Vertical centering is by extremes: peak y136 and trough y376 each sit exactly 120 (23.4% of canvas) from canvas center y256, so the baseline lands at y268. Horizontal centering is by the full span: x 96 to 416, midpoint exactly 256 (the apex sits 12 left of center; that offset is correct). Strokes as percent of canvas: core 32 (6.25%), glow 40 (1.25x core), halo 54 (1.69x core), mono knockout 40; corner radius 116 (22.66%). At any badge size, hold these percentages. The angle and ratio numbers double as the authenticity check for any TITN mark in the wild.
Every lockup, treatment, badge, and favicon regenerates from one Python script (uses rsvg-convert). Edit the constants and re-run to rebuild the full set into Bold/SVG, Bold/PNG, and Bold/favicon.
Montserrat Bold is installed locally (~/Library/Fonts/) so the PNG wordmark text renders correctly. Keep that font available wherever the generator runs. Favicons render from the dark badge into favicon-{16,32,48,64,128,180,256,512}.png: point the site favicon at the 32 and 16, the apple-touch icon at 180, and app stores at 512 or the SVG badge.
Filenames were kept identical to v1 on purpose, so the Framer wireframe, marketing templates, and this bible (which all reference Bold/...) auto-show the new mark.
The reasoning behind each choice, so future edits stay aligned with intent rather than re-litigating settled calls.
Explored vesica piscis, Tesla 369 sacred geometry, and a brainwave-ripple mark. Landed on a clean single heartbeat with the spike dead-center and a forward arrow. The conceptual ideas were beautiful but busy; the clean pulse is stronger, scales further, and fits TITN's "proven, not promised" credibility.
An early version had a tiny downward Q dip just before the spike. At zoom it read as a defect or awkward kink, so it was removed. The baseline now runs straight into the spike.
Line ends switched to a flat butt cap (the old rounded end looked like a soft blurry nub next to the crisp arrow), and the halo was tightened so the whole line reads as a crisp lightsaber, not haze.
The glow gives the color cuts visual mass. A bare core-width mono looked too thin beside them, so mono strokes run ~1.65x the neon core weight to carry the same weight.
In the TITN-letter lockup the signal was overpowering the four letters. The signal was shrunk to a smaller accent so TITN is the hero. (The wordmark keeps the larger signal.)
Neon never survives shrinking. A rounded-square app-icon badge with a bold solid pulse plus a whisper of glow stays crisp to 16px. This is the favicon, app-icon, and minimized mark.
Red moved from "fully banned" to the functional error / problem color. Still never a brand color, but now usable for alerts and validation states. (See Section 09.)
TITN_Email_Signature.html pulls the 2024 logo hosted at transitionitnow.com/wp-content/.../TITN-LOGO-horizontal-for-light-bg.svg. It will not change until the new horizontal logo is uploaded to the site and the URL is swapped. Best tied to the Framer migration.favicon-* files.Bold/). Memory carries a standing rule to swap any old-logo holdout that turns up.The TITN palette is blue, white, black ONLY. Anything else needs explicit sign-off. The supporting blues are used inside the logo treatment only.
Any TITN page, deck, or document reads as roughly 60 percent surface, 30 percent ink, 10 percent blue. If a layout feels "too blue", it is over 10.
Letter-spacing Canva +15 across all Montserrat headers (= 0.015em). Bold (700) is the locked wordmark weight as of May 2026.
The +15 / +3 tracking specs above are Canva & InDesign units (1/1000 em). They do NOT translate 1:1 to other tools. In pptxgenjs, raw PPTX XML, or Google Slides, do not set any charSpacing value; use the font's natural letter spacing. Any non-zero value in those tools over-tracks the text to the point of unreadability.
The brand's "tracked" feel comes through naturally from Montserrat Bold's geometry. The proven TITN aesthetic (Weston-approved on the SPCVA Advisory Brief, May 2026) is: natural letter spacing, no charSpacing, restrained typography. This is the default for all TITN materials (decks, PDFs, briefs, one-pagers). Apply the +15 / +3 tracking specs only in Canva or Figma, where the InDesign-unit tracking renders correctly.
Locked May 2026 after Weston's sign-off on the SPCVA Advisory Brief. Use this pattern for all client-facing advisory deliverables unless a project calls for something different.
Visually friendly and professional, not over-aesthetic. Readability beats premium tracking.
charSpacing. Example: 01 · CREDENTIALS.#111315 (off-black, never pure #000000), lineSpacingMultiple: 1.05 to 1.1.#E2E7EE separating title from content.lineSpacingMultiple: 1.3 to 1.4.THE PRECEDENT, PRAGMATIC ORDER, etc.) and italic-muted body. Magazine pull-quote feel, not UI card.Roberto Beteta Jr. · 805-660-0793 · roberto@transitionitnow.com (charcoal, 9pt) + page count right-aligned (muted, 9pt) + line 2 Discussion draft. Not legal, billing, or coding advice. (italic muted, 8.5pt). Footer pattern is consistent across every page.Side-by-side PREPARED FOR | PREPARED BY blocks, equal row count on both sides for visual symmetry. PREPARED BY = Roberto's 4-line block (name / title · company / direct phone · email / website). Never add a TITN-main line below: Roberto's number IS the TITN main; 805-551-6088 is Weston's direct line, not a TITN general number.
charSpacing in pptxgenjs ever).#000000, use #111315.valign: "top").breakLine: true, items render as a concatenated wall.Reference deliverable: /Users/Weston/Downloads/createapowerfulletterforspcvaandresruizchuckherri/WAVi at SPCVA - Advisory Brief.pdf.
Don't narrate the client's emotional state back at them. Phrases like "I hear you," "I know that's frustrating," "I can tell you've been dealing with a lot" read as condescending and performative.
In client comms, apologize once cleanly, then state the action. Lead with the apology and the action, not the empathy. Treat the client as a competent peer.
Example open: "Apologies for the trouble the [X] error has been causing, and thanks for flagging it. Here's what we'll do:", then go straight to concrete steps.
On cover slides, the lecturer / credit line sits in muted gray (around #9CA8B5 or theme default), NOT TITN Blue. Blue is reserved for the eyebrow and italic accent words. The credit line is supporting metadata, not a primary accent. Same rule for supporting lines (hotel block notes, dates, etc.) keep them quiet so the price/date/title can carry the slide.
Frosted-glass panels, generous whitespace, soft gradients. Study these reference sites before making visual decisions:
The canonical TITN brand figure is the 3D human model. For hero imagery and product page graphics, re-treat this model for variants rather than generating new figures. It is the TITN brand body.
Master reference: /Users/Weston/Downloads/TITN/TITN FDA Clearance/TITN-FDA-Clearance-Reimbursement-Master-Tables-v1.3.xlsx · Check the Forbidden Claims sheet before drafting any regulated product copy.
K173696 vascular, K152216 sudomotor, K200141 HRV. Do NOT use "ANS+" name in regulated marketing; that's a TITN field nickname only.K213900. K162460 was the Research Desktop variant, voluntarily withdrawn, do not market.TBD. Position as cash-pay / wellness until verified.We exist to help traditional medical practices confidently expand into functional and preventive medicine by providing FDA-cleared diagnostic technologies that are insurance-reimbursed, creating immediate practice ROI, while simultaneously proving through systematic retesting which treatments actually improve patient health through objective biomarkers and health trend documentation.
We're not selling wellness devices hoping they work. We're providing the diagnostic infrastructure that proves what works, enabling traditional doctors to take their first confident steps into preventive medicine supported by both patient outcomes and practice revenue.